author-photo

M.A. Convery

56

Papers

7

Citations

Citation Trend

Filter By

Papers (37) Sort By

Journal Conference Others

Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target

2020 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (4)
Correction to Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel.

2020 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (1)
Optimization of Orally Bioavailable PI3K delta Inhibitors and Identification of Vps34 as a key off-target activity.

2020 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (1)
PI3K delta in complex with N[5(7{2[4(2hydroxypropan2yl)piperidin1 yl]ethoxy}1,3dihydro2benzofuran5yl)2 methoxypyridin3yl]methanesulfonamide

2020
Show All
- Source
- Cite
- Save
Citations (0)
PI3K delta in complex with 2methoxyN[2methoxy5(7{[(2R)4(oxetan3 yl)morpholin2yl]methoxy}1,3dihydro2 benzofuran5yl)pyridin3yl]ethane1 sulfonamide

2020
Show All
- Source
- Cite
- Save
Citations (0)
PI3K Delta in complex with methoxymethyloxathiatetraazatetracyclodocosahexaenedione

2020
Show All
- Source
- Cite
- Save
Citations (0)
PI3K delta in complex with N[5(7{2[4(2hydroxypropan2yl)piperidin1 yl]ethoxy}1,3dihydro2benzofuran5yl)2 methoxypyridin3yl]methanesulfonamide

2020
Show All
- Source
- Cite
- Save
Citations (0)
PI3K delta in complex with 2methoxyN[2methoxy5(7{[(2R)4(oxetan3 yl)morpholin2yl]methoxy}1,3dihydro2 benzofuran5yl)pyridin3yl]ethane1 sulfonamide

2020
Show All
- Source
- Cite
- Save
Citations (0)
RIP2 kinase catalytic domain complex with (5S,6S,8R)-2-(benzo[d]thiazol-5-yl)-6-hydroxy-4,5,6,7,8,9-hexahydro-5,8-methanopyrazolo[1,5-a][1,3]diazocine-3-carboxamide

2019
- L.M. Shewchuk
- M.A. Convery
Show All
- Source
- Cite
- Save
Citations (0)
PI3 Kinase Delta in complex with 3{6[(1S,6R)3oxabicyclo[4.1.0]heptan6yl]pyridin2yl}phenol

2019
Show All
- Source
- Cite
- Save
Citations (0)